Juliet A. Emamaullee - Publications

Caspase inhibitor therapy synergizes with costimulation blockade to promote indefinite islet allograft survival.

Journal: Diabetes

Published: March 25, 2010

Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: January 28, 2010

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

Journal: Diabetes

Published: March 18, 2009

Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide.

Journal: Endocrinology

Published: January 10, 2009

The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice.

Journal: Diabetes

Published: March 22, 2008

Belatacept and basiliximab diminish human antiporcine xenoreactivity and synergize to inhibit alloimmunity.

Journal: Transplantation

Published: January 15, 2008

Factors influencing the loss of beta-cell mass in islet transplantation.

Journal: Cell transplantation

Published: April 18, 2007

Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation.

Journal: Diabetes

Published: February 17, 2007

Interventional strategies to prevent beta-cell apoptosis in islet transplantation.

Journal: Diabetes

Published: June 29, 2006